 Home > Medical News > Latest Medical News > The original research drug soared by 374%!

The original research drug soared by 374%!

 Last Update: 2021-08-07
 Source: Internet
 Author: User

Tags

ativan drug

dnp drug

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On July 8, Chengdu Better Pharmaceuticals submitted an application for the imitation of Enpagliflozin Tablets for the 4th category, which was undertaken by CDE

Figure 1: The latest product status

Source: CDE official website

Enpagliflozin is a sodium-glucose cotransporter 2 (SGLT-2) inhibitor jointly developed by Boehringer Ingelheim and Eli Lilly.

In 2020, in China's urban public hospitals, county-level public hospitals, urban community centers and township health centers (Chinese public medical institutions) terminals and Chinese urban physical pharmacies, the total sales of the original Enpagliflozin tablets will exceed 100 million yuan.

Figure 2: Sales of Empagliflozin in physical pharmacies in Chinese cities (unit: ten thousand yuan)

Source: China City Entity Pharmacy Terminal of Meinenet

At present, 4 companies of domestic generic drugs of Enpagliflozin on the market have been approved.

Table 1: The latest status of diabetes-related products of Chengdu Better Pharmaceutical

Source: Meinenet MED2.

Chengdu Better Pharmaceuticals has obtained approvals for 3 products in the field of diabetes medication, including Gliclazide tablets (Ⅱ), lipoic acid injection and metformin hydrochloride sustained-release tablets

Source: CDE official website, Minet database

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

jobs united states(236)

united states jobs(223)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

ups united states(221)

announcements today(81)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.